DocumentationElectronic Health RecordsNatural Language Processing
Dr. Jacob Eli Berchuck, MD
NPI1215279617PAC ID8224321583
- Medicare services, 2024
- 79
- Medicare patients, 2024
- 77
- Part D claims, 2024
- 61
- Publications
- 43
- MIPS score, 2024
- 95
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Berchuck's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jacob Eli Berchuck is a medical oncologist in Boston, Massachusetts
Dr. Berchuck practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Dr. Berchuck's NPI, 1215279617, was assigned on March 23, 2013. Dr. Berchuck graduated from Duke University School of Medicine in 2013. Dr. Berchuck holds Massachusetts license 270610.
NPI and contact details
- NPI
- 1215279617NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8224321583
- NPI enumeration date
- March 23, 2013
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 39
- Medical school graduation
- 2013
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jacob Eli Berchuck practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Dr. Berchuck's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Dr. Jacob Eli Berchuck is affiliated with 3 sites of care and 2 medical groups
Dr. Berchuck's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Berchuck is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Berchuck to 1 more hospital and 1 medical group, each named with a free account.
Emory University HospitalEmory Clinic1 hospitalName with a free account1 medical groupName with a free account
See all 5 affiliations for Dr. BerchuckSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jacob Eli Berchuck's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berchuck practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Berchuck practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jacob Eli Berchuck is one of 290 medical oncologists in Massachusetts
Medical oncology is Dr. Berchuck's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Berchuck is licensed in Massachusetts.
Specialties and state licenses
- Medical oncology, MassachusettsPrimary
Medical oncologists near Dr. Berchuck
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
290medical oncologists in Massachusetts228medical oncologists in Boston96medical oncologists at Dana-Farber Cancer Institute
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jacob Eli Berchuck billed Medicare for 79 services in 2024
CMS data shows 79 Medicare services from Dr. Berchuck across 3 procedure codes in 2024, for 77 Medicare patients. Medicare paid $4,768 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 202479
Medicare patients77
Paid by Medicare$4,768
Procedure codes3
Dr. Berchuck's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1452024: 7946%
Dr. Berchuck compared with the Massachusetts median for medical oncologists, 2024
- Dr. Berchuck
- Massachusetts median
- Medicare services
- 79vs 26070% below
- Medicare patients
- 77vs 10929% below
- Part D claims
- 165vs 632.6 times
Medians across 259 medical oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Berchuck's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Berchuck?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Berchuck and other medical oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jacob Eli Berchuck treated 77 Medicare patients in 2024, average age 75
CMS counts 77 Medicare patients who saw Dr. Berchuck in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Berchuck's median patient age at 73, with 17% women.
Medicare patients, 202477
Average age75
Average risk score2.28
Dr. Berchuck's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Berchuck's Medicare patients by sex, 2024
- Women1114%
- Men6686%
Chronic conditions among Dr. Berchuck's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure73%
- Arthritis40%
- Diabetes29%
- Anxiety25%
- Atrial fibrillation25%
- Chronic kidney disease25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Berchuck's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women17%
- Men83%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jacob Eli Berchuck wrote 61 Medicare Part D claims in 2024
In 2024, Dr. Berchuck wrote 61 Medicare Part D claims for 21 patients. 64% of them were for generic drugs. They cover 6 drugs, with $611,501 in total drug cost. In 2022, CMS named 95 claims across 4 drugs.
Part D claims, 202461
Drugs named by CMS6
Total drug cost$611,501
Part D patients21
Dr. Berchuck's Part D claims by kind of drug, 2024
- Generic39 claims64%
- Brand-name and other22 claims36%
Dr. Berchuck's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 952023: 16574%
Drugs named by CMS: 6 in 2023, 4 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jacob Eli Berchuck scored 95 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Berchuck for performance year 2024, reported through an alternative payment model (APM). Dr. Berchuck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berchuck as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Berchuck's MIPS scores, performance year 2024
- 95of 100Final score
- 80.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Berchuck by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jacob Eli Berchuck has 43 publications on record
Dmand AI links 43 papers to Dr. Berchuck, published from 2013 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, Biomarkers, Tumor and Carcinoma, Renal Cell. Dr. Berchuck has published most often in Nat Commun. Dr. Berchuck's most frequent co-authors are Toni K. Choueiri, MD, Amin Nassar, MD and Himisha Beltran, MD.
Papers43
Years published2013 to 2025
Dr. Berchuck's papers by year, 2013 to 2025
Topics Dr. Berchuck writes about most
- Prostatic Neoplasms
- Biomarkers, Tumor
- Carcinoma, Renal Cell
- Epigenomics
- Gene Expression Regulation, Neoplastic
- Kidney Neoplasms
- Cell-Free Nucleic Acids
- DNA Methylation
Dr. Berchuck's most frequent co-authors
- Toni K. Choueiri, MD16 shared papers
- Amin Nassar, MD6 shared papers
- Himisha Beltran, MD4 shared papers
Recent publications by Dr. Berchuck
Ataxia Telangiectasia Mutated ProteinsBRCA2 ProteinCheckpoint Kinase 2
Bile Duct NeoplasmsCholangiocarcinomaDrug Resistance, Neoplasm
AdenocarcinomaHomologous RecombinationNeoplasm Metastasis
See who Dr. Berchuck researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Berchuck works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jacob Eli Berchuck received $2,559 in industry payments from 2022 to 2024
CMS Open Payments shows 4 general payments to Dr. Berchuck from 3 drug and device companies from 2022 to 2024. Consulting fees make up the largest share, 92% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,363.
General payments to Dr. Berchuck by program year, 2022 to 2024
General payments to Dr. Berchuck by kind, 2022 to 2024
$2.6Kin total
- Consulting fees$2,36392%
- Food and beverage$1968%
Companies that paid Dr. Berchuck the most, 2022 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jacob Eli Berchuck graduated from Duke University School of Medicine
Dr. Berchuck graduated from Duke University School of Medicine in 2013.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jacob Eli Berchuck's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jacob Eli Berchuck
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jacob Eli Berchuck's NPI number?
Dr. Jacob Eli Berchuck's NPI number is 1215279617. It was assigned on March 23, 2013, and it is active in the NPI Registry.
What kind of doctor is Dr. Jacob Eli Berchuck?
Dr. Jacob Eli Berchuck is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Jacob Eli Berchuck practice?
Dr. Berchuck practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Berchuck's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Berchuck to 1 hospital and 1 medical group.
What is Dr. Jacob Eli Berchuck's medical license number?
Dr. Berchuck holds Massachusetts license 270610.
Which hospitals is Dr. Jacob Eli Berchuck affiliated with?
Dr. Berchuck practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Berchuck is also affiliated with Emory University Hospital. Dmand AI links Dr. Berchuck to 1 more hospital.
What medical group is Dr. Jacob Eli Berchuck part of?
Dr. Berchuck is linked to Emory Clinic. Dmand AI links Dr. Berchuck to 1 more medical group.
Does Dr. Jacob Eli Berchuck accept Medicare?
Yes. CMS data shows Dr. Berchuck billed Medicare for 79 services in 2024, and Dr. Berchuck accepts Medicare assignment.
Does Dr. Jacob Eli Berchuck offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Berchuck as offering telehealth services.
What is Dr. Jacob Eli Berchuck's MIPS score?
Dr. Berchuck's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Jacob Eli Berchuck see?
CMS counts 77 Medicare patients who saw Dr. Berchuck in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Jacob Eli Berchuck bill to Medicare?
In 2024, Dr. Berchuck's most billed Medicare services were hospital inpatient care (99232), office visit, established patient (99214) and office visit, established patient (99213).
Where did Dr. Jacob Eli Berchuck go to medical school?
Dr. Berchuck graduated from Duke University School of Medicine in 2013.
What drugs does Dr. Jacob Eli Berchuck prescribe most?
In 2023 Medicare Part D data, Dr. Berchuck's most prescribed drugs by claims were Abiraterone Acetate, Nubeqa and Prednisone.
Has Dr. Jacob Eli Berchuck received payments from drug or device companies?
CMS Open Payments shows $2,559 in general payments to Dr. Berchuck from 3 companies from 2022 to 2024. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Jacob Eli Berchuck been practicing?
Dr. Berchuck graduated from medical school in 2013, 13 years ago.
Does Dr. Jacob Eli Berchuck do research?
Dmand AI links 43 publications to Dr. Berchuck, published from 2013 to 2025.
Who does Dr. Jacob Eli Berchuck publish with?
Dr. Berchuck's most frequent co-authors are Toni K. Choueiri, MD (16 shared papers), Amin Nassar, MD (6 shared papers) and Himisha Beltran, MD (4 shared papers).
Selling to medical oncology practices?
See medical oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card